|
1
|
Tiedemann F and Gmelin L: Einige neue
bestandtheile der galle des ochsen. Ann Phys. 85:326–337. 1827.
View Article : Google Scholar
|
|
2
|
Kim SJ, Lee HW and Gupta RC: Taurine, Bone
growth and bone development. Curr Nutr Food Sci. 4:135–144. 2008.
View Article : Google Scholar
|
|
3
|
Hayes KC, Carey RE and Schmidt SY: Retinal
degeneration associated with taurine deficiency in the cat.
Science. 188:949–951. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aerts L and Van Assche FA: Taurine and
taurine-deficiency in the perinatal period. J Perinat Med.
30:281–286. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chesney RW: Taurine: Its biological role
and clinical implications. Adv Pediatr. 32:1–42. 1985.PubMed/NCBI
|
|
6
|
Lee JY, Jung DW, Park HA, Kim SJ, Chung
JH, Moon CK and Kim YC: Effect of taurine on biliary excretion and
metabolism of acetaminophen in male hamsters. Biol Pharm Bull.
27:1792–1796. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu QR, López-Corcuera B, Nelson H,
Mandiyan S and Nelson N: Cloning and expression of a cDNA encoding
the transporter of taurine and beta-alanine in mouse brain. Proc
Natl Acad Sci USA. 89:12145–12149. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chesney RW, Lippincott S, Gusowski N,
Padilla M and Zelikovic I: Studies on renal adaptation to altered
dietary amino acid intake: Tissue taurine responses in nursing and
adult rats. J Nutr. 116:1965–1976. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Räihä NC, Heinonen K, Rassin DK and Gaull
GE: Milk protein quantity and quality in low-birthweight infants:
I. Metabolic responses and effects on growth. Pediatrics.
57:659–684. 1976.
|
|
10
|
Park E, Park SY, Wang C, Xu J, LaFauci G
and Schuller-Levis G: Cloning of murine cysteine sulfinic acid
decarboxylase and its mRNA expression in murine tissues. Biochim
Biophys Acta. 1574:403–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bella DL, Kwon YH, Hirschberger LL and
Stipanuk MH: Post-transcriptional regulation of cysteine
dioxygenase in rat liver. Adv Exp Med Biol. 483:71–85. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Redmond HP, Stapleton PP, Neary P and
Bouchier-Hayes D: Immunonutrition: The role of taurine. Nutrition.
14:599–604. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wójcik OP, Koenig KL, Zeleniuch-Jacquotte
A, Costa M and Chen Y: The potential protective effects of taurine
on coronary heart disease. Atherosclerosis. 208:19–25. 2010.
View Article : Google Scholar
|
|
14
|
Hansen SH: The role of taurine in diabetes
and the development of diabetic complications. Diabetes Metab Res
Rev. 17:330–346. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chesney RW, Han X and Patters AB: Taurine
and the renal system. J Biomed Sci. 17 (Suppl 1):S42010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huxtable RJ: Physiological actions of
taurine. Physiol Rev. 72:101–163. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sarsour EH, Kumar MG, Chaudhuri L, Kalen
AL and Goswami PC: Redox control of the cell cycle in health and
disease. Antioxid Redox Signal. 11:2985–3011. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiang JY: Bile acid metabolism and
signaling. Compr Physiol. 3:1191–212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goodman CA, Horvath D, Stathis C, Mori T,
Croft K, Murphy RM and Hayes A: Taurine supplementation increases
skeletal muscle force production and protects muscle function
during and after high-frequency in vitro stimulation. J Appl
Physiol (1985). 107:144–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sturman JA and Chesney RW: Taurine in
pediatric nutrition. Pediatr Clin North Am. 42:879–897. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lien YH, Shapiro JI and Chan L: Effects of
hypernatremia on organic brain osmoles. J Clin Invest.
85:1427–1435. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lang F, Madlung J, Uhlemann AC, Risler T
and Gulbins E: Cellular taurine release triggered by stimulation of
the Fas(CD95) receptor in Jurkat lymphocytes. Pflugers Arch.
436:377–383. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schaffer S, Takahashi K and Azuma J: Role
of osmoregulation in the actions of taurine. Amino Acids.
19:527–546. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yancey PH: Organic osmolytes as
compatible, metabolic and counteracting cytoprotectants in high
osmolarity and other stresses. J Exp Biol. 208:2819–2830. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Howard M, Fischer H, Roux J, Santos BC,
Gullans SR, Yancey PH and Welch WJ: Mammalian osmolytes and
S-nitrosoglutathione promote delta F508 cystic fibrosis
transmembrane conductance regulator (CFTR) protein maturation and
function. J Biol Chem. 278:35159–35167. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marcinkiewicz J and Kontny E: Taurine and
inflammatory diseases. Amino Acids. 46:7–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sukhotnik I, Aranovich I, Ben Shahar Y,
Bitterman N, Pollak Y, Berkowitz D, Chepurov D, Coran AG and
Bitterman A: Effect of taurine on intestinal recovery following
intestinal ischemia-reperfusion injury in a rat. Pediatr Surg Int.
32:161–168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gharibani P, Modi J, Menzie J,
Alexandrescu A, Ma Z, Tao R, Prentice H and Wu JY: Comparison
between single and combined post-treatment with
S-Methyl-N,N-diethylthiolcarbamate sulfoxide and taurine following
transient focal cerebral ischemia in rat brain. Neuroscience.
300:460–473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang Y, Zhang Y, Liu X, Zuo J, Wang K, Liu
W and Ge J: Exogenous taurine attenuates mitochondrial oxidative
stress and endoplasmic reticulum stress in rat cardiomyocytes. Acta
Biochim Biophys Sin (Shanghai). 45:359–367. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Z, Ohata Y, Watanabe Y, Yuan Y,
Yoshii Y, Kondo Y, Nishizono S and Chiba T: Taurine improves lipid
metabolism and increases resistance to oxidative stress. J Nutr Sci
Vitaminol (Tokyo). 66:347–356. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagai K, Fukuno S, Oda A and Konishi H:
Protective effects of taurine on doxorubicin-induced acute
hepatotoxicity through suppression of oxidative stress and
apoptotic responses. Anticancer Drugs. 27:17–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang CY, Shen CY, Kang CK, Sher YP, Sheu
WH, Chang CC and Lee TH: Taurine protects HK-2 cells from oxidized
LDL-induced cytotoxicity via the ROS-mediated mitochondrial and
p53-related apoptotic pathways. Toxicol Appl Pharmacol.
279:351–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Prideaux M, Kitase Y, Kimble M, O'Connell
TM and Bonewald LF: Taurine, an osteocyte metabolite, protects
against oxidative stress-induced cell death and decreases
inhibitors of the Wnt/β-catenin signaling pathway. Bone.
137:1153742020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lou J, Han D, Yu H, Yu G, Jin M and Kim
SJ: Cytoprotective effect of taurine against hydrogen
peroxide-induced oxidative stress in UMR-106 cells through the
Wnt/β-catenin signaling pathway. Biomol Ther (Seoul). 26:584–590.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suzuki T, Suzuki T, Wada T, Saigo K and
Watanabe K: Taurine as a constituent of mitochondrial tRNAs: New
insights into the functions of taurine and human mitochondrial
diseases. EMBO J. 21:6581–6589. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schaffer SW, Jong CJ, Ito T and Azuma J:
Role of taurine in the pathologies of MELAS and MERRF. Amino Acids.
46:47–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Homma K, Toda E, Osada H, Nagai N, Era T,
Tsubota K, Okano H and Ozawa Y: Taurine rescues
mitochondria-related metabolic impairments in the patient-derived
induced pluripotent stem cells and epithelial-mesenchymal
transition in the retinal pigment epithelium. Redox Biol.
41:1019212021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sturman JA: Taurine in development.
Physiol Rev. 73:119–147. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lima L, Obregón F, Urbina M, Carreira I,
Baccichet E and Peña S: Taurine concentration in human blood
peripheral lymphocytes. In: Taurine 5. Advances in Experimental
Medicine and Biology. Lombardini JB, Schaffer SW and Azuma J: 526.
Springer; Boston, MA: pp. 297–304. 2013
|
|
40
|
Iruloh CG, D'Souza SW, Speake PF, Crocker
I, Fergusson W, Baker PN, Sibley CP and Glazier JD: Taurine
transporter in fetal T lymphocytes and platelets: Differential
expression and functional activity. Am J Physiol Cell Physiol.
292:C332–C341. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Oja SS and Saransaari P: Taurine 6.
Advances in Experimental Medicine and Biology. 583. Springer; New
York, NY: pp. p5562006
|
|
42
|
Lubec B, Ya-hua Z, Pertti S, Pentti T,
Kitzmüller E and Lubec G: Distribution and disappearance of the
radiolabeled carbon derived from L-arginine and taurine in the
mouse. Life Sci. 60:2373–2381. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Menzie J, Pan C, Prentice H and Wu JY:
Taurine and central nervous system disorders. Amino Acids.
46:31–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Schaffer SW, Jong CJ, Ramila KC and Azuma
J: Physiological roles of taurine in heart and muscle. J Biomed
Sci. 17 (Suppl 1):S22010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schaffer SW, Shimada-Takaura K, Jong CJ,
Ito T and Takahashi K: Impaired energy metabolism of the
taurine-deficient heart. Amino Acids. 48:549–558. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jong CJ, Azuma J and Schaffer S: Mechanism
underlying the antioxidant activity of taurine: Prevention of
mitochondrial oxidant production. Amino Acids. 42:2223–2232. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jong C, Ito T, Mozaffari M, Azuma J and
Schaffer S: Effect of beta-alanine treatment on mitochondrial
taurine level and 5-taurinomethyluridine content. J Biomed Sci. 17
(Suppl 1):S252010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Vafai SB and Mootha VK: Mitochondrial
disorders as windows into an ancient organelle. Nature.
491:374–833. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jansen M, Ten Klooster JP, Offerhaus GJ
and Clevers H: LKB1 and AMPK family signaling: The intimate link
between cell polarity and energy metabolism. Physiol. 89:777–798.
2009.PubMed/NCBI
|
|
50
|
Jong CJ, Azuma J and Schaffer SW: Role of
mitochondrial permeability transition in taurine deficiency-induced
apoptosis. Exp Clin Cardiol. 16:125–128. 2011.PubMed/NCBI
|
|
51
|
Ricci C, Pastukh V, Leonard J, Turrens J,
Wilson G, Schaffer D and Schaffer SW: Mitochondrial DNA damage
triggers mitochondrial-superoxide generation and apoptosis. Am J
Physiol Cell Physiol. 294:C413–C422. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shetewy A, Shimada-Takaura K, Warner D,
Jong CJ, Mehdi AB, Alexeyev M, Takahashi K and Schaffer SW:
Mitochondrial defects associated with β-alanine toxicity: Relevance
to hyper-beta-alaninemia. Mol Cell Biochem. 416:11–22. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Schuller-Levis G and Park E: Is taurine a
biomarker? Adv Clin Chem. 41:1–21. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Cozzi R, Ricordy R, Bartolini F, Ramadori
L, Perticone P and De Salvia R: Taurine and ellagic acid: Two
differently-acting natural antioxidants. Environ Mol Mutagen.
26:248–254. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Aruoma OI, Halliwell B, Hoey BM and Butler
J: The antioxidant action of taurine, hypotaurine and their
metabolic precursors. Biochem J. 256:251–255. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Timbrell JA, Seabra V and Waterfield CJ:
The in vivo and in vitro protective properties of taurine. Gen
Pharmacol. 26:453–462. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen WQ, Jin H, Nguyen M, Carr J, Lee YJ,
Hsu CC, Faiman MD, Schloss JV and Wu JY: Role of taurine in
regulation of intracellular calcium level and neuroprotective
function in cultured neurons. J Neurosci Res. 66:612–619. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yamauchi-Takihara K, Azuma J, Kishimoto S,
Onishi S and Sperelakis N: Taurine prevention of calcium
paradox-related damage in cardiac muscle. Its regulatory action on
intracellular cation contents. Biochem Pharmacol. 37:2651–2658.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Parvez S, Tabassum H, Banerjee BD and
Raisuddin S: Taurine prevents tamoxifen-induced mitochondrial
oxidative damage in mice. Basic Clin Pharmacol Toxicol.
102:382–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Sener G, Ozer Sehirli A, Ipçi Y, Cetinel
S, Cikler E, Gedik N and Alican I: Taurine treatment protects
against chronic nicotine-induced oxidative changes. Fundam Clin
Pharmacol. 155–164. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Şener G, Şehirli Ö, İpçi Y, Çetinel Ş,
Çikler E, Gedik N and Alican I: Protective effects of taurine
against nicotine-induced oxidative damage of rat urinary bladder
and kidney. Pharmacology. 74:37–44. 2005. View Article : Google Scholar
|
|
62
|
Jafri AJA, Agarwal R, Iezhitsa I, Agarwal
P and Ismail NM: Taurine protects against NMDA-induced retinal
damage by reducing retinal oxidative stress. Amino Acids.
51:641–646. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gordon RE and Heller RF and Heller RF:
Taurine protection of lungs in hamster models of oxidant injury: A
morphologic time study of paraquat and bleomycin treatment.
Taurine. Advances in Experimental Medicine and Biology. Lombardini
JB, Schaffer SW and Azuma J: 315. Springer; Boston, MA: pp.
319–328. 1992, View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kim C and Cha YN: Taurine chloramine
produced from taurine under inflammation provides anti-inflammatory
and cytoprotective effects. Amino Acids. 46:89–100. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hsieh TJ, Zhang SL, Filep JG, Tang SS,
Ingelfinger JR and Chan JS: High glucose stimulates angiotensinogen
gene expression via reactive oxygen species generation in rat
kidney proximal tubular cells. Endocrinology. 143:2975–2985. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Kettle AJ, van Dalen CJ and Winterbourn
CC: Peroxynitrite and myeloperoxidase leave the same footprint in
protein nitration. Redox Rep. 3:257–258. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Schaffer S, Solodushko V, Pastukh V, Ricci
C and Azuma J: Possible cause of taurine-deficient cardiomyopathy:
Potentiation of angiotensin II action. J Cardiovasc Pharmacol.
41:751–759. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Vohra BP and Hui X: Taurine protects
against carbon tetrachloride toxicity in the cultured neurons and
in vivo. Arch Physiol Biochem. 109:90–94. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Nonaka H, Tsujino T, Watari Y, Emoto N and
Yokoyama M: Taurine prevents the decrease in expression and
secretion of extracellular superoxide dismutase induced by
homocysteine: Amelioration of homocysteine-induced endoplasmic
reticulum stress by taurine. Circulation. 104:1165–1170. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Anand P, Rajakumar D, Jeraud M, Felix AJ
and Balasubram T: Effects of taurine on glutathione peroxidase,
glutathione reductase and reduced glutathione levels in rats. Pak J
Biol Sci. 14:219–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Oudit GY, Trivieri MG, Khaper N, Husain T,
Wilson GJ, Liu P, Sole MJ and Backx PH: Taurine supplementation
reduces oxidative stress and improves cardiovascular function in an
iron-overload murine model. Circulation. 109:1877–1885. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Das J and Sil PC: Taurine ameliorates
alloxan-induced diabetic renal injury, oxidative stress-related
signaling pathways and apoptosis in rats. Amino Acids.
43:1509–1523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Sayed RH, Salem HA and El-Sayeh BM:
Potential protective effect of taurine against
dibromoacetonitrile-induced neurotoxicity in rats. Environ Toxicol
Pharmacol. 34:849–857. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Das J, Ghosh J, Manna P and Sil PC:
Taurine protects rat testes against doxorubicin-induced oxidative
stress as well as p53, Fas and caspase 12-mediated apoptosis. Amino
Acids. 42:1839–1855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Bhavsar TM, Cantor JO, Patel SN and
Lau-Cam CA: Attenuating effect of taurine on
lipopolysaccharide-induced acute lung injury in hamsters. Pharmacol
Res. 60:418–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ito T, Schaffer SW and Azuma J: The
potential usefulness of taurine on diabetes mellitus and its
complications. Amino Acids. 42:1529–1539. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Rikimaru M, Ohsawa Y, Wolf AM, Nishimaki
K, Ichimiya H, Kamimura N, Nishimatsu S, Ohta S and Sunada Y:
Taurine ameliorates impaired the mitochondrial function and
prevents stroke-like episodes in patients with MELAS. Intern Med.
51:3351–3357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hagar HH, El Etter E and Arafa M: Taurine
attenuates hypertension and renal dysfunction induced by
cyclosporine a in rats. Clin Exp Pharmacol Physiol. 33:189–196.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Shao X, Hu Z, Hu C, Bu Q, Yan G, Deng P,
Lv L, Wu D, Deng Y, Zhao J, et al: Taurine protects
methamphetamine-induced developmental angiogenesis defect through
antioxidant mechanism. Toxicol Appl Pharmacol. 260:260–270. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Brosnan JT and Brosnan ME: The
sulfur-containing amino acids: An overview. J Nutr. 136 (Suppl
6):1636S–1640S. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wenting L, Ping L, Haitao J, Meng Q and
Xiaofei R: Therapeutic effect of taurine against aluminum-induced
impairment on learning, memory and brain neurotransmitters in rats.
Neurol. 35:1579–1584. 2014.PubMed/NCBI
|
|
82
|
Albrecht J and Schousboe A: Taurine
interaction with neurotransmitter receptors in the CNS: An update.
Neurochem Res. 30:1615–1621. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wu H, Jin Y, Wei J, Jin H, Sha D and Wu
JY: Mode of action of taurine as a neuroprotector. Brain Res.
1038:123–131. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Chen C, Xia S, He J, Lu G, Xie Z and Han
H: Roles of taurine in cognitive function of physiology,
pathologies and toxication. Life Sci. 231:1165842019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Ochoa-de la Paz L, Zenteno E,
Gulias-Cañizo R and Quiroz-Mercado H: Taurine and GABA
neurotransmitter receptors, a relationship with therapeutic
potential? Expert Rev Neurother. 19:289–291. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhou J, Li Y, Yan G, Bu Q, Lv L, Yang Y,
Zhao J, Shao X, Deng Y, Zhu R, et al: Protective role of taurine
against morphine-induced neurotoxicity in C6 cells via inhibition
of oxidative stress. Neurotox Res. 20:334–342. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Bulley S and Shen W: Reciprocal regulation
between taurine and glutamate response via
Ca2+-dependent pathways in retinal third-order neurons.
J Biomed Sci. 17 (Suppl 1):S52010. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Makarova LM, Pogorelyĭ VE, Voronkov AV and
Novikova NA: Modern notions about the role of taurine in the
central nervous system. Eksp Klin Farmakol. 77:38–44. 2014.(In
Russian). PubMed/NCBI
|
|
89
|
Wu JY and Prentice H: Role of taurine in
the central nervous system. J Biomed Sci. 17 (Suppl 1):S12010.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhang C, Liu F, Liu X and Chen D:
Protective effect of N-acetylcysteine against BDE-209-induced
neurotoxicity in primary cultured neonatal rat hippocampal neurons
in vitro. Int J Dev Neurosci. 28:521–528. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Abramov AY and Duchen MR: Mechanisms
underlying the loss of mitochondrial membrane potential in
glutamate excitotoxicity. Biochim Biophys Acta. 1777:953–964. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Prentice H, Modi JP and Wu JY: Mechanisms
of neuronal protection against excitotoxicity, endoplasmic
reticulum stress, and mitochondrial dysfunction in stroke and
neurodegenerative diseases. Oxid Med Cell Longev. 2015:9645182015.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
McCullough KD, Martindale JL, Klotz LO, Aw
TY and Holbrook NJ: Gadd153 sensitizes cells to endoplasmic
reticulum stress by down-regulating Bcl2 and perturbing the
cellular redox state. Mol Cell Biol. 21:1249–1259. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Urano F, Wang X, Bertolotti A, Zhang Y,
Chung P, Harding HP and Ron D: Coupling of stress in the ER to
activation of JNK protein kinases by transmembrane protein kinase
IRE1. Science. 287:664–666. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Zhang R, Jiang M, Zhang J, Qiu Y, Li D, Li
S, Liu J, Liu C, Fang Z and Cao F: Regulation of the
cerebrovascular smooth muscle cell phenotype by mitochondrial
oxidative injury and endoplasmic reticulum stress in simulated
microgravity rats via the PERK-eIF2α-ATF4-CHOP pathway. Biochim
Biophys Acta Mol Basis Dis. 1866:1657992020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Aslan Karakelle N, Dinçer S and Yar Sağlam
AS: The effect of intracerebroventricular amyloid beta 1–42
application on cognitive functions in aged rats supplemented with
taurine and the change of peroxisomal proteins in this process.
Brain Res Bull. 172:89–97. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Lee DS and Cheong SH: Taurine have
neuroprotective activity against oxidative damage-induced HT22 Cell
death through heme oxygenase-1 pathway. Taurine 10. Advances in
Experimental Medicine and Biology. Lee DH, Schaffer SW, Park E and
Kim HW: 975. Springer; Dordrecht: pp. 159–171. 2017, View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zhang X, Wang X, Zhang J, Pan X, Jiang J
and Li Y: Effects of taurine on alterations of neurobehavior and
neurodevelopment key proteins expression in infant rats by exposure
to hexabromocyclododecane. Taurine 10. Advances in Experimental
Medicine and Biology. Lee DH, Schaffer SW, Park E and Kim HW: 975.
Springer; Dordrecht: pp. 119–30. 2017, View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Chen R, Liu S, Piao F, Wang Z, Qi Y, Li S,
Zhang D and Shen J: 2,5-hexanedione induced apoptosis in
mesenchymal stem cells from rat bone marrow via
mitochondria-dependent caspase-3 pathway. Ind Health. 53:222–235.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Liu S, Piao F, Sun X, Bai L, Peng Y, Zhong
Y, Ma N and Sun W: Arsenic-induced inhibition of hippocampal
neurogenesis and its reversibility. Neurotoxicology. 33:1033–1039.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Yorifuji T, Kato T, Ohta H, Bellinger DC,
Matsuoka K and Grandjean P: Neurological and neuropsychological
functions in adults with a history of developmental arsenic
poisoning from contaminated milk powder. Neurotoxicol Teratol.
53:75–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Li K, Wang D, Zhou X, Shao J, Li Y, Liu X,
Zhang C, Zuo E, Shi X, Piao F and Li S: Taurine protects against
arsenic-induced apoptosis Via PI3K/Akt pathway in primary cortical
neurons. In: Taurine 11. Advances in Experimental Medicine and
Biology. Hu J, Piao F, Schaffer SW, El Idrissi A and Wu JY: 1155.
Springer; Singapore: pp. 747–754. 2019, PubMed/NCBI
|
|
103
|
Piao F, Zhang Y, Yang L, Zhang C, Shao J,
Liu X, Li Y and Li S: Taurine attenuates As2O3-induced autophagy in
cerebrum of mouse through Nrf2 pathway. Adv Exp Med Biol.
975:863–870. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Cholanians AB, Phan AV, Ditzel EJ,
Camenisch TD, Lau SS and Monks TJ: From the cover: Arsenic induces
accumulation of α-synuclein: Implications for synucleinopathies and
neurodegeneration. Toxicol Sci. 153:271–281. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Escudero-Lourdes C: Toxicity mechanisms of
arsenic that are shared with neurodegenerative diseases and
cognitive impairment: Role of oxidative stress and inflammatory
responses. Neurotoxicology. 53:223–235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Lee J, Giordano S and Zhang J: Autophagy,
mitochondria and oxidative stress: Cross-talk and redox signalling.
Biochem J. 441:523–540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zhu XX, Yao XF, Jiang LP, Geng CY, Zhong
LF, Yang G, Zheng BL and Sun XC: Sodium arsenite induces
ROS-dependent autophagic cell death in pancreatic β-cells. Food
Chem Toxicol. 70:144–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Li Y, Hu Z, Chen B, Bu Q, Lu W, Deng Y,
Zhu R, Shao X, Hou J, Zhao J, et al: Taurine attenuates
methamphetamine-induced autophagy and apoptosis in PC12 cells
through mTOR signaling pathway. Toxicol Lett. 215:1–7. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Menzie J, Prentice H and Wu JY:
Neuroprotective mechanisms of taurine against ischemic stroke.
Brain Sci. 3:877–907. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Schaffer SW, Jong CJ, Ito T and Azuma J:
Effect of taurine on ischemia-reperfusion injury. Amino Acids.
46:21–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Yamori Y, Liu L, Mori M, Sagara M,
Murakami S, Nara Y and Mizushima S: Taurine as the nutritional
factor for the longevity of the japanese revealed by a world-wide
epidemiological survey. In: Taurine 7. Advances in Experimental
Medicine and Biology. Azuma J, Schaffer SW and Ito T: 643.
Springer; New York, NY: pp. 13–25. 2009, PubMed/NCBI
|
|
112
|
Lotocki G, de Rivero Vaccari JP, Perez ER,
Sanchez-Molano J, Furones-Alonso O, Bramlett HM and Dietrich WD:
Alterations in blood-brain barrier permeability to large and small
molecules and leukocyte accumulation after traumatic brain injury:
Effects of post-traumatic hypothermia. J Neurotrauma. 26:1123–1134.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Sun Q, Hu H, Wang W, Jin H, Feng G and Jia
N: Taurine attenuates amyloid β 1–42-induced mitochondrial
dysfunction by activating of SIRT1 in SK-N-SH cells. Biochem
Biophys Res Commun. 447:485–489. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Niu X, Zheng S, Liu H and Li S: Protective
effects of taurine against inflammation, apoptosis, and oxidative
stress in brain injury. Mol Med Rep. 18:4516–4522. 2018.PubMed/NCBI
|
|
115
|
Saransaari P and Oja SS: Enhanced taurine
release in cultured cerebellar granule cells in cell-damaging
conditions. Amino Acids. 17:323–334. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Ricci L, Valoti M, Sgaragli G and Frosini
M: Protection by taurine of rat brain cortical slices against
oxygen glucose deprivation- and reoxygenation-induced damage. Eur J
Pharmacol. 621:26–32. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Abramov AY, Scorziello A and Duchen MR:
Three distinct mechanisms generate oxygen free radicals in neurons
and contribute to cell death during anoxia and reoxygenation. J
Neurosci. 27:1129–1138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Han Z, Gao LY, Lin YH, Chang L, Wu HY, Luo
CX and Zhu DY: Neuroprotection of taurine against reactive oxygen
species is associated with inhibiting NADPH oxidases. Eur J
Pharmacol. 777:129–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Pion PD, Kittleson MD, Rogers QR and
Morris JG: Myocardial failure in cats associated with low plasma
taurine: A reversible cardiomyopathy. Science. 237:764–768. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Moise NS, Pacioretty LM, Kallfelz FA,
Stipanuk MH, King JM and Gilmour RF Jr: Dietary taurine deficiency
and dilated cardiomyopathy in the fox. Am Heart J. 121:541–547.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Lake N: Loss of cardiac myofibrils:
Mechanism of contractile deficits induced by taurine deficiency. Am
J Physiol. 264:H1323–H1326. 1993.PubMed/NCBI
|
|
122
|
Ito T, Kimura Y, Uozumi Y, Takai M,
Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, et al:
Taurine depletion caused by knocking out the taurine transporter
gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell
Cardiol. 44:927–937. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Ito T, Oishi S, Takai M, Kimura Y, Uozumi
Y, Fujio Y, Schaffer SW and Azuma J: Cardiac and skeletal muscle
abnormality in taurine transporter-knockout mice. J Biomed Sci. 17
(Suppl 1):S202010. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Huxtable R and Bressler R: Taurine
concentrations in congestive heart failure. Science. 184:1187–1188.
1974. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Jacobsen JG and Smith LH: Biochemistry and
physiology of taurine and taurine derivatives. Physiol Rev.
48:424–511. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Huxtable RJ and Sebring LA: Cardiovascular
actions of taurine. Prog Clin Biol Res. 125:5–37. 1983.PubMed/NCBI
|
|
127
|
Suwanich A, Wyss JM and Roysommuti S:
Taurine supplementation in spontaneously hypertensive rats:
Advantages and limitations for human applications. World J Cardiol.
5:404–409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Bousquet P, Feldman J, Bloch R and
Schwartz J: Central cardiovascular effects of taurine: Comparison
with homotaurine and muscimol. J Pharmacol Exp Ther. 219:213–218.
1981.PubMed/NCBI
|
|
129
|
Satoh H: Cardioprotective actions of
taurine against intracellular and extracellular calcium-induced
effects. Taurine in Health and Disease. Advances in Experimental
Medicine and Biology. Huxtable RJ and Michalk D: 359. Springer;
Boston, MA: pp. 181–196. 1994, View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Qi B, Yamagami T, Naruse Y, Sokejima S and
Kagamimori S: Effects of taurine on depletion of erythrocyte
membrane Na-K ATPase activity due to ozone exposure or cholesterol
enrichment. J Nutr Sci Vitaminol (Tokyo). 41:627–634. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Petty MA, Kintz J and DiFrancesco GF: The
effects of taurine on atherosclerosis development in
cholesterol-fed rabbits. Eur J Pharmacol. 180:119–127. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Murakami S, Sakurai T, Tomoike H, Sakono
M, Nasu T and Fukuda N: Prevention of hypercholesterolemia and
atherosclerosis in the hyperlipidemia- and atherosclerosis-prone
Japanese (LAP) quail by taurine supplementation. Amino Acids.
38:271–278. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Murakami S, Nara Y and Yamori Y: Taurine
accelerates the regression of hypercholesterolemia in stroke-prone
spontaneously hypertensive rats. Life Sci. 58:1643–1651. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Yokogoshi H, Mochizuki H, Nanami K, Hida
Y, Miyachi F and Oda H: Dietary taurine enhances cholesterol
degradation and reduces serum and liver cholesterol concentrations
in rats fed a high-cholesterol diet. J Nutr. 129:1705–1712. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Lam NV, Chen W, Suruga K, Nishimura N,
Goda T and Yokogoshi H: Enhancing effect of taurine on CYP7A1 mRNA
expression in Hep G2 cells. Amino Acids. 30:43–48. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Bellentani S, Pecorari M, Cordoma P,
Marchegiano P, Manenti F, Bosisio E, De Fabiani E and Galli G:
Taurine increases bile acid pool size and reduces bile saturation
index in the hamster. J Lipid Res. 28:1021–1027. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Yanagita T, Han SY, Hu Y, Nagao K,
Kitajima H and Murakami S: Taurine reduces the secretion of
apolipoprotein B100 and lipids in HepG2 cells. Lipids Health Dis.
7:382008. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Ulrich-Merzenich G, Zeitler H, Vetter H
and Bhonde RR: Protective effects of taurine on endothelial cells
impaired by high glucose and oxidized low density lipoproteins. Eur
J Nutr. 46:431–438. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Gokce G, Ozsarlak-Sozer G, Oran I, Oktay
G, Ozkal S and Kerry Z: Taurine suppresses oxidative
stress-potentiated expression of lectin-like oxidized low-density
lipoprotein receptor and restenosis in balloon-injured rabbit iliac
artery. Clin Exp Pharmacol Physiol. 38:811–818. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Matsushima Y, Sekine T, Kondo Y, Sakurai
T, Kameo K, Tachibana M and Murakami S: Effects of taurine on serum
cholesterol levels and development of atherosclerosis in
spontaneously hyperlipidaemic mice. Clin Exp Pharmacol Physiol.
30:295–299. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Murakami S, Kondo-Ohta Y and Tomisawa K:
Improvement in cholesterol metabolism in mice given chronic
treatment of taurine and fed a high-fat diet. Life Sci. 64:83–91.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Chen W, Guo JX and Chang P: The effect of
taurine on cholesterol metabolism. Mol Nutr Food Res. 56:681–690.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Mochizuki H, Takido J and Yokogoshi H:
Effect of dietary taurine on endogenous hypercholesterolemia in
rats fed on phenobarbital-containing diets. Biosci Biotechnol
Biochem. 63:1298–1300. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Mochizuki H, Oda H and Yokogoshi H:
Dietary taurine potentiates polychlorinated biphenyl-induced
hypercholesterolemia in rats*. J Nutr Biochem. 12:109–115. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Zulli A, Lau E, Wijaya BP, Jin X, Sutarga
K, Schwartz GD, Learmont J, Wookey PJ, Zinellu A, Carru C and Hare
DL: High dietary taurine reduces apoptosis and atherosclerosis in
the left main coronary artery: Association with reduced
CCAAT/enhancer binding protein homologous protein and total plasma
homocysteine but not lipidemia. Hypertension. 53:1017–1022. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Tan B, Jiang DJ, Huang H, Jia SJ, Jiang
JL, Hu CP and Li YJ: Taurine protects against low-density
lipoprotein-induced endothelial dysfunction by the DDAH/ADMA
pathway. Vascul Pharmacol. 46:338–345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Elvevoll EO, Eilertsen KE, Brox J, Dragnes
BT, Falkenberg P, Olsen JO, Kirkhus B, Lamglait A and Østerud B:
Seafood diets: Hypolipidemic and antiatherogenic effects of taurine
and n-3 fatty acids. Atherosclerosis. 200:396–402. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
di Wu Q, Wang JH, Fennessy F, Redmond HP
and Bouchier-Hayes D: Taurine prevents high-glucose-induced human
vascular endothelial cell apoptosis. Am J Physiol. 277:C1229–C1238.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Katakawa M, Fukuda N, Tsunemi A, Mori M,
Maruyama T, Matsumoto T, Abe M and Yamori Y: Taurine and magnesium
supplementation enhances the function of endothelial progenitor
cells through antioxidation in healthy men and spontaneously
hypertensive rats. Hypertens Res. 39:848–856. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Chang L, Xu J, Yu F, Zhao J, Tang X and
Tang C: Taurine protected myocardial mitochondria injury induced by
hyperhomocysteinemia in rats. Amino Acids. 27:37–48. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Ghosh J, Das J, Manna P and Sil PC:
Taurine prevents arsenic-induced cardiac oxidative stress and
apoptotic damage: Role of NF-kappa B, p38 and JNK MAPK pathway.
Toxicol Appl Pharmacol. 240:73–87. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Mousavi K, Niknahad H, Ghalamfarsa A,
Mohammadi H, Azarpira N, Ommati MM and Heidari R: Taurine mitigates
cirrhosis-associated heart injury through mitochondrial-dependent
and antioxidative mechanisms. Clin Exp Hepatol. 6:207–219. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Liu J, Ai Y, Niu X, Shang F, Li Z, Liu H,
Li W, Ma W, Chen R, Wei T, et al: Taurine protects against cardiac
dysfunction induced by pressure overload through SIRT1-p53
activation. Chem Biol Interact. 317:1089722020. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Chen G, Nan C, Tian J, Jean-Charles P, Li
Y, Weissbach H and Huang XP: Protective effects of taurine against
oxidative stress in the heart of MsrA knockout mice. J Cell
Biochem. 113:3559–3566. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Rashid K, Das J and Sil PC: Taurine
ameliorate alloxan induced oxidative stress and intrinsic apoptotic
pathway in the hepatic tissue of diabetic rats. Food Chem Toxicol.
51:317–329. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Sevin G, Ozsarlak-Sozer G, Keles D, Gokce
G, Reel B, Ozgur HH, Oktay G and Kerry Z: Taurine inhibits
increased MMP-2 expression in a model of oxidative stress induced
by glutathione depletion in rabbit heart. Eur J Pharmacol.
706:98–106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Hansen SH, Andersen ML, Cornett C,
Gradinaru R and Grunnet N: A role for taurine in mitochondrial
function. J Biomed Sci. 17 (Suppl 1):S232010. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Oriyanhan W, Yamazaki K, Miwa S, Takaba K,
Ikeda T and Komeda M: Taurine prevents myocardial
ischemia/reperfusion-induced oxidative stress and apoptosis in
prolonged hypothermic rat heart preservation. Heart Vessels.
20:278–285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Sahin MA, Yucel O, Guler A, Doganci S,
Jahollari A, Cingoz F, Arslan S, Gamsizkan M, Yaman H and
Demirkilic U: Is there any cardioprotective role of Taurine during
cold ischemic period following global myocardial ischemia? J
Cardiothorac Surg. 6:312011. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Venturini A, Ascione R, Lin H, Polesel E,
Angelini GD and Suleiman MS: The importance of myocardial amino
acids during ischemia and reperfusion in dilated left ventricle of
patients with degenerative mitral valve disease. Mol Cell Biochem.
330:63–70. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Xu YJ, Arneja AS, Tappia PS and Dhalla NS:
The potential health benefits of taurine in cardiovascular disease.
Exp Clin Cardiol. 13:57–65. 2008.PubMed/NCBI
|
|
162
|
Jacobus WE, Tiozzo R, Lugli G, Lehninger
AL and Carafoli E: Aspects of energy-linked calcium accumulation by
rat heart mitochondria. J Biol Chem. 250:7863–7870. 1975.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Rasola A and Bernardi P: Mitochondrial
permeability transition in Ca(2+)-dependent apoptosis and necrosis.
Cell Calcium. 50:222–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Zhang Y, Yang L, Yang YJ, Liu XY, Jia JG,
Qian JY, Wang KQ, Zuo J and Ge J: Low-dose taurine upregulates
taurine transporter expression in acute myocardial ischemia. Int J
Mol Med. 31:817–824. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Schaffer S, Solodushko V and Azuma J:
Taurine-deficient cardiomyopathy: Role of phospholipids, calcium
and osmotic stress. Taurine 4. Advances in Experimental Medicine
and Biology. Della Corte L, Huxtable RJ, Sgaragli G and Tipton KF:
483. Springer; Boston, MA: pp. 57–69. 2002, View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Bagchi D, Wetscher GJ, Bagchi M, Hinder
PR, Perdikis G, Stohs SJ, Hinder RA and Das DK: Interrelationship
between cellular calcium homeostasis and free radical generation in
myocardial reperfusion injury. Chem Biol Interact. 104:65–85. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Grace PA: Ischaemia-reperfusion injury. Br
J Surg. 81:637–647. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Lemasters JJ, Nieminen AL, Qian T, Trost
LC and Herman B: The mitochondrial permeability transition in
toxic, hypoxic and reperfusion injury. Mol Cell Biochem.
174:159–165. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Kaplan B, Aricioglu A, Erbas D, Erbas S
and Turkozkan N: The effects of taurine on perfused heart muscle
malondialdehyde levels. Gen Pharmacol. 24:1411–1413. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Ramila KC, Jong CJ, Pastukh V, Ito T,
Azuma J and Schaffer SW: Role of protein phosphorylation in
excitation-contraction coupling in taurine deficient hearts. Am J
Physiol-Heart Circ Physiol. 308:H232–H239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Modi P and Suleiman MS: Myocardial
taurine, development and vulnerability to ischemia. Amino Acids.
26:65–70. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Tricarico D, Barbieri M and Camerino DC:
Taurine blocks ATP-sensitive potassium channels of rat skeletal
muscle fibres interfering with the sulphonylurea receptor. Br J
Pharmacol. 130:827–834. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Tricarico D, Barbieri M and Conte Camerino
D: Voltage-dependent antagonist/agonist actions of taurine on
Ca(2+)-activated potassium channels of rat skeletal muscle fibers.
J Pharmacol Exp Ther. 298:1167–1171. 2001.PubMed/NCBI
|
|
174
|
Shimada K, Jong CJ, Takahashi K and
Schaffer SW: Role of ROS Production and Turnover in the Antioxidant
Activity of Taurine. Taurine. 9:Marcinkiewicz J and Schaffer SW:
581–96. 2015.
|
|
175
|
Takatani T, Takahashi K, Uozumi Y, Shikata
E, Yamamoto Y, Ito T, Matsuda T, Schaffer SW, Fujio Y and Azuma J:
Taurine inhibits apoptosis by preventing formation of the
Apaf-1/caspase-9 apoptosome. Am J Physiol Cell Physiol.
287:C949–C953. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Li Y, Arnold JM, Pampillo M, Babwah AV and
Peng T: Taurine prevents cardiomyocyte death by inhibiting NADPH
oxidase-mediated calpain activation. Free Radic Biol Med. 46:51–61.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Ahmadi S and Mehranjani MS: Taurine
improves follicular survival and function of mice ovarian grafts
through increasing CD31 and GDF9 expression and reducing oxidative
stress and apoptosis. Eur J Pharmacol. 903:1741342021. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Ito T, Yoshikawa N, Schaffer SW and Azuma
J: Tissue taurine depletion alters metabolic response to exercise
and reduces running capacity in mice. J Amino Acids.
2014:9646802014. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Bakker AJ and Berg HM: Effect of taurine
on sarcoplasmic reticulum function and force in skinned fast-twitch
skeletal muscle fibres of the rat. J Physiol. 538:185–194. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Thirupathi A, Pinho RA, Baker JS, István B
and Gu Y: Taurine reverses oxidative damages and restores the
muscle function in overuse of exercised muscle. Front Physiol.
11:5824492020. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Dutka TL, Lamboley CR, Murphy RM and Lamb
GD: Acute effects of taurine on sarcoplasmic reticulum
Ca2+ accumulation and contractility in human type I and
II skeletal muscle fibers. J Appl Physiol. 117:797–805. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
182
|
De Luca A, Pierno S and Camerino DC:
Taurine: The appeal of a safe amino acid for skeletal muscle
disorders. J Transl Med. 13:2432015. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
De Luca A, Pierno S and Camerino DC:
Effect of taurine depletion on excitation-contraction coupling and
Cl-conductance of rat skeletal muscle. Eur J Pharmacol.
296:215–222. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Jentsch TJ: CLC chloride channels and
transporters: From genes to protein structure, pathology and
physiology. Crit Rev Biochem Mol Biol. 43:3–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Hamilton EJ, Berg HM, Easton CJ and Bakker
AJ: The effect of taurine depletion on the contractile properties
and fatigue in fast-twitch skeletal muscle of the mouse. Amino
Acids. 31:273–278. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Tallis J, Higgins MF, Cox VM, Duncan MJ
and James RS: Does a physiological concentration of taurine
increase acute muscle power output, time to fatigue, and recovery
in isolated mouse soleus (slow) muscle with or without the presence
of caffeine? Can J Physiol Pharmacol. 92:42–49. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Yatabe Y, Miyakawa S, Miyazaki T,
Matsuzaki Y and Ochiai N: Effects of taurine administration in rat
skeletal muscles on exercise. J Orthop Sci. 8:415–419. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Ohmori H, Matsumura M, Komine S, Kobayashi
H, Kobayashi Y, Shiromoto J and Miyakawa S: The production of a rat
model that inhibits phosphoenolpyruvate carboxykinase (PEPCK), a
rate-limiting enzyme of hepatic gluconeogenesis. Taurine 11.
Advances in Experimental Medicine and Biology. Hu J, Piao F,
Schaffer SW, El Idrissi A and Wu JY: 1155. Springer; Singapore: pp.
113–118. 2019, View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Zachariah Tom R, Garcia-Roves PM, Sjögren
RJ, Jiang LQ, Holmström MH, Deshmukh AS, Vieira E, Chibalin AV,
Björnholm M and Zierath JR: Effects of AMPK activation on insulin
sensitivity and metabolism in leptin-deficient ob/ob mice.
Diabetes. 63:1560–1571. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Beloshapka AN, de Godoy MR, Carter RA,
Fascetti AJ, Yu Z, McIntosh BJ, Swanson KS and Buff PR:
Longitudinal changes in blood metabolites, amino acid profile, and
oxidative stress markers in American foxhounds fed a
nutrient-fortified diet. J Anim Sci. 96:930–940. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Dawson R Jr, Biasetti M, Messina S and
Dominy J: The cytoprotective role of taurine in exercise-induced
muscle injury. Amino Acids. 22:309–324. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Silva LA, Silveira PC, Ronsani MM, Souza
PS, Scheffer D, Vieira LC, Benetti M, De Souza CT and Pinho RA:
Taurine supplementation decreases oxidative stress in skeletal
muscle after eccentric exercise. Cell Biochem Funct. 29:43–49.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Marcinkiewicz J: Taurine bromamine: A new
therapeutic option in inflammatory skin diseases. Pol Arch Med
Wewn. 119:673–676. 2009.PubMed/NCBI
|
|
194
|
Kato T, Okita S, Wang S, Tsunekawa M and
Ma N: The effects of Taurine administration against inflammation in
heavily exercised skeletal muscle of rats. Taurine 9. Advances in
Experimental Medicine and Biology. Marcinkiewicz J and Schaffer SW:
803. Springer; New York, NY: pp. 773–784. 2015, View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Sugiura H, Okita S, Kato T, Naka T,
Kawanishi S, Ohnishi S, Oshida Y and Ma N: Protection by taurine
against INOS-dependent DNA damage in heavily exercised skeletal
muscle by inhibition of the NF-κB signaling pathway. Taurine 8.
Advances in Experimental Medicine and Biology. El Idrissi A and
L'Amoreaux WJ: 775. Springer; New York, NY: pp. 237–246. 2013,
View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Moyes CD: Controlling muscle mitochondrial
content. J Exp Biol. 206:4385–4391. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Nikolaidis MG and Mougios V: Effects of
exercise on the fatty-acid composition of blood and tissue lipids.
Sports Med. 34:1051–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Nikolaidis MG, Petridou A and Mougios V:
Comparison of the phospholipid and triacylglycerol fatty acid
profile of rat serum, skeletal muscle and heart. Physiol Res.
55:259–265. 2006.PubMed/NCBI
|
|
199
|
Imagawa TF, Hirano I, Utsuki K, Horie M,
Naka A, Matsumoto K and Imagawa S: Caffeine and taurine enhance
endurance performance. Int J Sports Med. 30:485–488. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Mikami N, Hosokawa M and Miyashita K:
Dietary combination of fish oil and taurine decreases fat
accumulation and ameliorates blood glucose levels in type 2
diabetic/obese KK-A(y) mice. J Food Sci. 77:H114–H120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Ra SG, Miyazaki T, Ishikura K, Nagayama H,
Komine S, Nakata Y, Maeda S, Matsuzaki Y and Ohmori H: Combined
effect of branched-chain amino acids and taurine supplementation on
delayed onset muscle soreness and muscle damage in high-intensity
eccentric exercise. J Int Soc Sports Nutr. 10:512013. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Galloway SD, Talanian JL, Shoveller AK,
Heigenhauser GJ and Spriet LL: Seven days of oral taurine
supplementation does not increase muscle taurine content or alter
substrate metabolism during prolonged exercise in humans. J Appl
Physiol (1985). 105:643–651. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
D'Antona G, Nabavi SM, Micheletti P, Di
Lorenzo A, Aquilani R, Nisoli E, Rondanelli M and Daglia M:
Creatine, L-carnitine, and ω3 polyunsaturated fatty acid
supplementation from healthy to diseased skeletal muscle. Biomed
Res Int. 2014:6138902014.
|
|
204
|
Rutherford JA, Spriet LL and Stellingwerff
T: The effect of acute taurine ingestion on endurance performance
and metabolism in well-trained cyclists. Int J Sport Nutr Exerc
Metab. 20:322–329. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Balshaw TG, Bampouras TM, Barry TJ and
Sparks SA: The effect of acute taurine ingestion on 3-km running
performance in trained middle-distance runners. Amino Acids.
44:555–561. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
da Silva LA, Tromm CB, Bom KF, Mariano I,
Pozzi B, da Rosa GL, Tuon T, da Luz G, Vuolo F, Petronilho F, et
al: Effects of taurine supplementation following eccentric exercise
in young adults. Appl Physiol Nutr Metab. 39:101–104. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Ra SG, Choi Y, Akazawa N, Kawanaka K,
Ohmori H and Maeda S: Effects of taurine supplementation on
vascular endothelial function at rest and after resistance
exercise. Taurine 11. Advances in Experimental Medicine and
Biology. Hu J, Piao F, Schaffer SW, El Idrissi A and Wu JY: 1155.
Springer; Singapore: pp. 407–414. 2019, View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Zhang M, Izumi I, Kagamimori S, Sokejima
S, Yamagami T, Liu Z and Qi B: Role of taurine supplementation to
prevent exercise-induced oxidative stress in healthy young men.
Amino Acids. 26:203–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Chupel MU, Minuzzi LG, Furtado GE, Santos
ML, Ferreira JP, Filaire E and Teixeira AM: Taurine supplementation
reduces myeloperoxidase and matrix-metalloproteinase-9 levels and
improves the effects of exercise in cognition and physical fitness
in older women. Amino Acids. 53:333–435. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
De Paepe B, Martin JJ, Herbelet S,
Jimenez-Mallebrera C, Iglesias E, Jou C, Weis J and De Bleecker JL:
Activation of osmolyte pathways in inflammatory myopathy and
Duchenne muscular dystrophy points to osmoregulation as a
contributing pathogenic mechanism. Lab Invest. 96:872–884. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Pierno S, Liantonio A, Camerino GM, De
Bellis M, Cannone M, Gramegna G, Scaramuzzi A, Simonetti S, Nicchia
GP, Basco D, et al: Potential benefits of taurine in the prevention
of skeletal muscle impairment induced by disuse in the
hindlimb-unloaded rat. Amino Acids. 43:431–445. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Uozumi Y, Ito T, Hoshino Y, Mohri T, Maeda
M, Takahashi K, Fujio Y and Azuma J: Myogenic differentiation
induces taurine transporter in association with taurine-mediated
cytoprotection in skeletal muscles. Biochem J. 394:699–706. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Terrill JR, Grounds MD and Arthur PG:
Taurine deficiency, synthesis and transport in the mdx mouse model
for Duchenne muscular dystrophy. Int J Biochem Cell Biol.
66:141–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Cozzoli A, Nico B, Sblendorio VT,
Capogrosso RF, Dinardo MM, Longo V, Gagliardi S, Montagnani M and
De Luca A: Enalapril treatment discloses an early role of
angiotensin II in inflammation- and oxidative stress-related muscle
damage in dystrophic mdx mice. Pharmacol Res. 64:482–492. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Jaeschke H: Reactive oxygen and mechanisms
of inflammatory liver injury. J Gastroenterol Hepatol. 15:718–724.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Warskulat U, Borsch E, Reinehr R,
Heller-Stilb B, Mönnighoff I, Buchczyk D, Donner M, Flögel U,
Kappert G, Soboll S, et al: Chronic liver disease is triggered by
taurine transporter knockout in the mouse. FASEB J. 20:574–576.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Chen X, Sebastian BM, Tang H, McMullen MM,
Axhemi A, Jacobsen DW and Nagy LE: Taurine supplementation prevents
ethanol-induced decrease in serum adiponectin and reduces hepatic
steatosis in rats. Hepatology. 49:1554–1562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Goc Z, Kapusta E, Formicki G, Martiniaková
M and Omelka R: Effect of taurine on ethanol-induced oxidative
stress in mouse liver and kidney. Chin J Physiol. 62:148–156. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Lin CJ, Chiu CC, Chen YC, Chen ML, Hsu TC
and Tzang BS: Taurine attenuates hepatic inflammation in chronic
alcohol-fed rats through inhibition of TLR4/MyD88 signaling. J Med
Food. 18:1291–1298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Murakami S, Ono A, Kawasaki A, Takenaga T
and Ito T: Taurine attenuates the development of hepatic steatosis
through the inhibition of oxidative stress in a model of
nonalcoholic fatty liver disease in vivo and in vitro. Amino Acids.
50:1279–1288. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Zhang Z, Liu D, Yi B, Liao Z, Tang L, Yin
D and He M: Taurine supplementation reduces oxidative stress and
protects the liver in an iron-overload murine model. Mol Med Rep.
10:2255–2262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Choi MJ and Jung YJ: Effects of taurine
and vitamin d on antioxidant enzyme activity and lipids profiles in
rats fed diet deficient calcium. Taurine 10. Advances in
Experimental Medicine and Biology. Lee DH, Schaffer SW, Park E and
Kim HW: 975. Springer; Dordrecht: pp. 1081–1092. 2017, View Article : Google Scholar : PubMed/NCBI
|
|
223
|
Abdel-Daim MM, Dessouki AA, Abdel-Rahman
HG, Eltaysh R and Alkahtani S: Hepatorenal protective effects of
taurine and N-acetylcysteine against fipronil-induced injuries: The
antioxidant status and apoptotic markers expression in rats. Sci
Total Environ. 650:2063–2073. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Hoang MH, Jia Y, Jun H, Lee JH, Hwang KY,
Choi DW, Um SJ, Lee BY, You SG and Lee SJ: Taurine is a liver X
receptor-α ligand and activates transcription of key genes in the
reverse cholesterol transport without inducing hepatic lipogenesis.
Mol Nutr Food Res. 56:900–911. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Geyeregger R, Zeyda M and Stulnig TM:
Liver X receptors in cardiovascular and metabolic disease. Cell Mol
Life. 63:524–539. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
226
|
Cao PJ, Jin YJ, Li ME, Zhou R and Yang MZ:
PGC-1α may associated with the anti-obesity effect of taurine on
rats induced by arcuate nucleus lesion. Nutr Neurosci. 19:86–93.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Mizushima S, Nara Y, Sawamura M and Yamori
Y: Effects of oral taurine supplementation on lipids and
sympathetic nerve tone. Taurine 2. Advances in Experimental
Medicine and Biology. Huxtable RJ, Azuma J, Kuriyama K, Nakagawa M
and Baba A: 403. Springer; Boston, MA: pp. 615–622. 1996,
View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Zhang M, Bi LF, Fang JH, Su XL, Da GL,
Kuwamori T and Kagamimori S: Beneficial effects of taurine on serum
lipids in overweight or obese non-diabetic subjects. Amino Acids.
26:267–271. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Miyazaki T, Karube M, Matsuzaki Y, Ikegami
T, Doy M, Tanaka N and Bouscarel B: Taurine inhibits oxidative
damage and prevents fibrosis in carbon tetrachloride-induced
hepatic fibrosis. J Hepatol. 43:117–125. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Abd-Elhakim YM, Ghoneim MH, Ebraheim LLM
and Imam TS: Taurine and hesperidin rescues carbon
tetrachloride-triggered testicular and kidney damage in rats via
modulating oxidative stress and inflammation. Life Sci.
254:1177822020. View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Burlacu A, Genovesi S, Ortiz A, Combe C,
Basile C, Schneditz D, van der Sande F, Popa GT, Morosanu C and
Covic A: Pros and cons of antithrombotic therapy in end-stage
kidney disease: A 2019 update. Nephrol Dial Transplant. 34:923–933.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Ijiri Y, Ikarugi H, Tamura Y, Ura M,
Morishita M, Hamada A, Mori M, Mori H, Yamori Y, Ishii H and
Yamamoto J: Antithrombotic effect of taurine in healthy Japanese
people may be related to an increased endogenous thrombolytic
activity. Thromb Res. 131:158–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Lee WM: Acetaminophen toxicity: Changing
perceptions on a social/medical issue. Hepatology. 46:966–970.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
234
|
Bessems JG and Vermeulen NP: Paracetamol
(acetaminophen)-induced toxicity: Molecular and biochemical
mechanisms, analogues and protective approaches. Crit Rev Toxicol.
31:55–138. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
235
|
Jaeschke H, Knight TR and Bajt ML: The
role of oxidant stress and reactive nitrogen species in
acetaminophen hepatotoxicity. Toxicol Lett. 144:279–288. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Hinson JA, Roberts DW and James LP:
Mechanisms of acetaminophen-induced liver necrosis. Adverse Drug
Reactions. Handbook of Experimental Pharmacology. Uetrecht J: 196.
Springer; Berlin: pp. 369–405. 2010, View Article : Google Scholar : PubMed/NCBI
|
|
237
|
Acharya M and Lau-Cam CA: Comparison of
the protective actions of N-acetylcysteine, hypotaurine and taurine
against acetaminophen-induced hepatotoxicity in the rat. J Biomed
Sci. 17 (Suppl 1):S352010. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Acharya M and Lau-Cam CA: Comparative
evaluation of the effects of taurine and thiotaurine on alterations
of the cellular redox status and activities of antioxidant and
glutathione-related enzymes by acetaminophen in the rat. Taurine 8.
Advances in Experimental Medicine and Biology. El Idrissi A and
L'Amoreaux WJ: 776. Springer; New York, NY: pp. 199–215. 2013,
View Article : Google Scholar : PubMed/NCBI
|
|
239
|
Ghandforoush-Sattari M and Mashayekhi S:
Evaluation of taurine as a biomarker of liver damage in paracetamol
poisoning. Eur J Pharmacol. 581:171–176. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Boşgelmez İİ, Söylemezoğlu T and Güvendik
G: The protective and antidotal effects of taurine on hexavalent
chromium-induced oxidative stress in mice liver tissue. Biol Trace
Elem Res. 125:46–58. 2008. View Article : Google Scholar
|
|
241
|
Tabassum H, Rehman H, Banerjee BD,
Raisuddin S and Parvez S: Attenuation of tamoxifen-induced
hepatotoxicity by taurine in mice. Clin Chim Acta. 370:129–136.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Patrick L: Lead toxicity part II: The role
of free radical damage and the use of antioxidants in the pathology
and treatment of lead toxicity. Altern Med Rev. 11:114–127.
2006.PubMed/NCBI
|
|
243
|
Hwang DF, Wang LC and Cheng HM: Effect of
taurine on toxicity of copper in rats. Food Chem Toxicol.
36:239–244. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Hwang D and Wang LC: Effect of taurine on
toxicity of cadmium in rats. Toxicology. 167:173–180. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
245
|
Jamshidzadeh A, Heidari R, Abasvali M,
Zarei M, Ommati MM, Abdoli N, Khodaei F, Yeganeh Y, Jafari F, Zarei
A, et al: Taurine treatment preserves brain and liver mitochondrial
function in a rat model of fulminant hepatic failure and
hyperammonemia. Biomed Pharmacother. 86:514–520. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
246
|
Doğru-Abbasoğlu S, Kanbağli O, Balkan J,
Cevikbaş U, Aykaç-Toker G and Uysal M: The protective effect of
taurine against thioacetamide hepatotoxicity of rats. Hum Exp
Toxicol. 20:23–27. 2001. View Article : Google Scholar
|
|
247
|
Bardach AE, Ciapponi A, Soto N, Chaparro
MR, Calderon M, Briatore A, Cadoppi N, Tassara R and Litter MI:
Epidemiology of chronic disease related to arsenic in Argentina: A
systematic review. Sci Total Environ. 538:802–816. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
248
|
Li S, Yang L, Dong G and Wang X: Taurine
protects mouse liver against arsenic-induced apoptosis through JNK
pathway. Taurine 10. Advances in Experimental Medicine and Biology.
Lee DH, Schaffer SW, Park E and Kim HW: 975. Springer; Dordrecht:
pp. 855–862. 2017, View Article : Google Scholar : PubMed/NCBI
|
|
249
|
Taranukhin AG, Taranukhina EY, Saransaari
P, Pelto-Huikko M, Podkletnova IM and Oja SS: Taurine protects
cerebellar neurons of the external granular layer against
ethanol-induced apoptosis in 7-day-old mice. Amino Acids.
43:1705–1711. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
250
|
Lau A, Zheng Y, Tao S, Wang H, Whitman SA,
White E and Zhang DD: Arsenic inhibits autophagic flux, activating
the Nrf2-Keap1 pathway in a p62-dependent manner. Mol Cell Biol.
33:2436–2446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
251
|
Bai J, Yao X, Jiang L, Zhang Q, Guan H,
Liu S, Wu W, Qiu T, Gao N, Yang L, et al: Taurine protects against
As2O3-induced autophagy in livers of rat offsprings through PPARγ
pathway. Sci Rep. 6:277332016. View Article : Google Scholar : PubMed/NCBI
|
|
252
|
Qiu T, Pei P, Yao X, Jiang L, Wei S, Wang
Z, Bai J, Yang G, Gao N, Yang L, et al: Taurine attenuates
arsenic-induced pyroptosis and nonalcoholic steatohepatitis by
inhibiting the autophagic-inflammasomal pathway. Cell Death Dis.
9:9462018. View Article : Google Scholar : PubMed/NCBI
|
|
253
|
Flora SJS, Chouhan S, Kannan GM, Mittal M
and Swarnkar H: Combined administration of taurine and monoisoamyl
DMSA protects arsenic induced oxidative injury in rats. Oxid Med
Cell Longev. 1:39–45. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
254
|
Cao W, Zhou Y, Li Y, Zhang X, He M, Zang
N, Zhou Y and Liao M: iTRAQ-based proteomic analysis of combination
therapy with taurine, epigallocatechin gallate, and genistein on
carbon tetrachloride-induced liver fibrosis in rats. Toxicol Lett.
232:233–245. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
255
|
El-Houseini ME, El-Agoza IA, Sakr MM and
El-Malky GM: Novel protective role of curcumin and taurine
combination against experimental hepatocarcinogenesis. Exp Ther
Med. 13:29–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
256
|
Abd-Rabou AA, Zoheir KMA and Ahmed HH:
Potential impact of curcumin and taurine on human hepatoma cells
using Huh-7 cell line. Clin Biochem. 45:1519–1521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
257
|
Pan MH, Yang G, Li S, Li MY, Tsai ML, Wu
JC, Badmaev V, Ho CT and Lai CS: Combination of citrus
polymethoxyflavones, green tea polyphenols, and Lychee extracts
suppresses obesity and hepatic steatosis in high-fat diet induced
obese mice. Mol Nutr Food Res. 61:2017. View Article : Google Scholar
|
|
258
|
Balkan J, Kanbagli Ö, Hatipoglu A, Küçük
M, Çevikbas U, Aykaç-Toker G and Uysal M: Improving effect of
dietary taurine supplementation on the oxidative stress and lipid
levels in the plasma, liver and aorta of rabbits fed on a
high-cholesterol diet. Biosci Biotechnol Biochem. 66:1755–1758.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
259
|
Cetiner M, Sener G, Sehirli AO,
Ekşioğlu-Demiralp E, Ercan F, Sirvanci S, Gedik N, Akpulat S,
Tecimer T and Yeğen BC: Taurine protects against
methotrexate-induced toxicity and inhibits leukocyte death. Toxicol
Appl Pharmacol. 209:39–50. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
260
|
Kalaz EB, Çoban J, Aydın AF, Doğan-Ekici
I, Doğru- Abbasoğlu S, Öztezcan S and Uysal M: Carnosine and
taurine treatments decreased oxidative stress and tissue damage
induced by D-galactose in rat liver. J Physiol Biochem. 70:15–25.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
261
|
Shi X, Yao D and Chen C: Identification of
N-acetyltaurine as a novel metabolite of ethanol through
metabolomics-guided biochemical analysis. J Biol Chem.
287:6336–6349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
262
|
Heidari R, Babaei H and Eghbal MA:
Amodiaquine-induced toxicity in isolated rat hepatocytes and the
cytoprotective effects of taurine and/or N-acetyl cysteine. Res
Pharm Sci. 9:97–105. 2014.PubMed/NCBI
|
|
263
|
Timbrell JA and Waterfield CJ: Changes in
taurine as an indicator of hepatic dysfunction and biochemical
perturbations. Taurine 2. Advances in Experimental Medicine and
Biology. Huxtable RJ, Azuma J, Kuriyama K, Nakagawa M and Baba A:
403. Springer; Boston, MA: pp. 125–134. 1996, View Article : Google Scholar : PubMed/NCBI
|
|
264
|
Gordon RE, Park E, Laskin D and
Schuller-Levis GB: Taurine protects rat bronchioles from acute
ozone exposure: A freeze fracture and electron microscopic study.
Exp Lung Res. 24:659–674. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
265
|
Venkatachalam S, Kuppusamy P, Kuppusamy B
and Dhanapal S: The potency of essential nutrient taurine on
boosting the antioxidant status and chemopreventive effect against
benzo (a)pyrene induced experimental lung cancer. Biomed Prev Nutr.
4:251–255. 2014. View Article : Google Scholar
|
|
266
|
Gurujeyalakshmi G, Wang Y and Giri SN:
Suppression of bleomycin-induced nitric oxide production in mice by
taurine and niacin. Nitric Oxide. 4:399–411. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
267
|
Wang Q, Hollinger MA and Giri SN:
Attenuation of amiodarone-induced lung fibrosis and
phospholipidosis in hamsters by taurine and/or niacin treatment. J
Pharmacol Exp Ther. 262:127–132. 1992.PubMed/NCBI
|
|
268
|
Izumi K, Nagata R, Motoya T, Yamashita J,
Hirokane T, Nagata T, Satoh Y, Sawada Y, Ishibashi M, Yoshida H, et
al: Preventive effect of taurine against acute paraquat
intoxication in beagles. Jpn J Pharmacol. 50:229–233. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
269
|
Li S, Wang J, Wei BK, Dong G and Wang X:
Protective effect of taurine on paraquat-induced lung epithelial
cell injury. Taurine 11. Advances in Experimental Medicine and
Biology. Hu J, Piao F, Schaffer SW, El Idrissi A and Wu JY: 1155.
Springer; Singapore: pp. 739–746. 2019, View Article : Google Scholar : PubMed/NCBI
|
|
270
|
Khalili Fard J, Hamzeiy H, Sattari M and
Eghbal MA: Protective roles of N-acetyl cysteine and/or taurine
against sumatriptan-induced hepatotoxicity. Adv Pharm Bull.
6:627–637. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
271
|
Gordon RE, Shaked AA and Solano DF:
Taurine protects hamster bronchioles from acute
NO2-induced alterations. A histologic, ultrastructural,
and freeze-fracture study. Am J Pathol. 125:585–600.
1986.PubMed/NCBI
|
|
272
|
Jeon SH, Lee MY, Rahman MM, Kim SJ, Kim
GB, Park SY, Hong CU, Kim SZ, Kim JS and Kang HS: The antioxidant,
taurine reduced lipopolysaccharide (LPS)-induced generation of ROS,
and activation of MAPKs and Bax in cultured pneumocytes. Pulm
Pharmacol Ther. 22:562–566. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
273
|
Das J, Ghosh J, Manna P, Sinha M and Sil
PC: Taurine protects rat testes against NaAsO(2)-induced oxidative
stress and apoptosis via mitochondrial dependent and independent
pathways. Toxicol Lett. 187:201–210. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
274
|
Meizel S: Molecules that initiate or help
stimulate the acrosome reaction by their interaction with the
mammalian sperm surface. Am J Anat. 174:285–302. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
275
|
Aly HA and Khafagy RM: Taurine reverses
endosulfan-induced oxidative stress and apoptosis in adult rat
testis. Food Chem Toxicol. 64:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
276
|
Azab SS, kamel I, Ismail NN, El Din Hosni
H and El Fatah MA: The defensive role of taurine against
gonadotoxicity and testicular apoptosis effects induced by
cisplatin in rats. J Infect Chemother. 26:51–57. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
277
|
Yahyavy S, Valizadeh A, Saki G and
Khorsandi L: Taurine induces autophagy and inhibits oxidative
stress in mice Leydig cells. JBRA Assist Reprod. 24:250–256.
2020.PubMed/NCBI
|
|
278
|
Kalender S, Apaydin FG and Kalender Y:
Testicular toxicity of orally administrated bisphenol A in rats and
protective role of taurine and curcumin. Pak J Pharm Sci.
32:1043–1047. 2019.PubMed/NCBI
|
